Myricetin Increases Circulating Adropin Level after Activation of Glucagon-like Peptide 1 (GLP-1) Receptor in Type-1 Diabetic Rats
Myricetin is a common plant-derived flavonoid, considered an agonist of glucagon-like peptide 1 (GLP-1) receptor. It improves glycemic control and helps reduce body weight in diabetic subjects. The potential mechanisms of action of myricetin in this context might be enhancing the secretion of β-endo...
Main Authors: | Ying-Xiao Li, Kai-Chun Cheng, I-Min Liu, Ho-Shan Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/2/173 |
Similar Items
-
Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
by: Kai-Chun Cheng, et al.
Published: (2020-11-01) -
Differential circulating concentrations of adipokines, glucagon and adropin in a clinical population of lean, overweight and diabetic cats
by: Rizaldy C. Zapata, et al.
Published: (2017-04-01) -
Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023-02-01) -
Endogenous opioid signaling in the retina modulates sleep/wake activity in mice
by: Casey-Tyler Berezin, et al.
Published: (2022-11-01) -
Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus
by: Naomi Niisato, et al.
Published: (2023-05-01)